PureTech Health (LON:PRTC) Trading 10.9% Higher – What’s Next?

PureTech Health plc (LON:PRTC) shot up 10.9% during mid-day trading on Friday . The company traded as high as GBX 118 ($1.59) and last traded at GBX 118 ($1.59). 1,631,935 shares were traded during trading, an increase of 120% from the average session volume of 740,986 shares. The stock had previously closed at GBX 106.40 ($1.43).

PureTech Health Stock Performance

The company has a quick ratio of 2.51, a current ratio of 3.68 and a debt-to-equity ratio of 45.82. The company has a market cap of £293.65 million, a PE ratio of 714.71 and a beta of 1.02. The stock’s 50 day simple moving average is GBX 129.46 and its two-hundred day simple moving average is GBX 129.76.

Insider Activity at PureTech Health

In other news, insider Bharatt Chowrira acquired 167,739 shares of the business’s stock in a transaction that occurred on Thursday, July 3rd. The shares were purchased at an average cost of GBX 1 per share, for a total transaction of £1,677.39. Company insiders own 13.13% of the company’s stock.

About PureTech Health

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.